Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

IntroductionMajor depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing ...

IV therapy has been used for decades in hospitals to treat a range of conditions, from dehydration to nutrient-absorption disorders, but it's increasingly offered at independent clinics and ...

The updated platform offers streamlined access to advanced mental health and anti-aging treatments. PHOENIX, AZ, UNITED STATES, February 17, 2 ...

Dr. Howard Schumaker and Tina Schumaker to open Relevate Ketafusion clinic in La Crosse, offering IV ketamine therapy for ...

Peacock is revisiting Matthew Perry's death in a new documentary that aims to take a deeper look into the investigation.

There’s news this week about a new store in Galesville, a new clinic in La Crosse and an insurance agency’s new Holmen ...

Peacock is set to release an upcoming investigative documentary, Matthew Perry: A Hollywood Tragedy, People reported on ...

In addition, it owns and operates two ketamine infusion treatment clinics; and thirteen ketamine infusion treatment clinics. The company is headquartered in Vancouver, Canada.